M3V — MeVis Medical Solutions AG Income Statement
0.000.00%
Last trade - 00:00- €44.41m
- €37.88m
- €16.06m
- 93
- 49
- 62
- 82
Annual income statement for MeVis Medical Solutions AG, fiscal year end - September 30th, EUR millions except per share, conversion factor applied.
2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | 2025 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | GAS | GAS | GAS | GAS | GAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 16.2 | 18.8 | 17.3 | 17 | 16.1 |
| Cost of Revenue | |||||
| Gross Profit | 15.8 | 18 | 16.9 | 16.5 | 15.7 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 11.7 | 11.1 | 13.4 | 13.5 | 13.9 |
| Operating Profit | 4.48 | 7.7 | 3.89 | 3.5 | 2.14 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 4.63 | 7.88 | 5.03 | 4.69 | 3.28 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 4.55 | 7.79 | 4.92 | 4.56 | 3.17 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 4.55 | 7.79 | 4.92 | 4.56 | 3.17 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 4.55 | 7.79 | 4.92 | 4.56 | 3.17 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 2.5 | 4.28 | 2.7 | 2.51 | 1.74 |
| Dividends per Share |